Contribute Try STAT+ Today

Good morning, everyone, and welcome to another working week. We hope the weekend respite — if that is the correct word — was somehow distracting and invigorating. Now, though, the time has come to embrace the usual routine of deadlines, conference calls, and to-do lists, even if we are doing so in isolation. So reach for a cup of stimulation — our choice today is caramel vanilla — and prepare to forge ahead. Meanwhile, here are a few items of interest to get you going. Stay in touch and stay safe.

France reported 43 cases of heart incidents linked to treating coronavirus patients with hydroxychloroquine, the malaria drug President Trump has repeatedly touted as a potential “game changer,” Bloomberg News writes. As the U.S. stockpiles as many as 29 million doses of the drug, which is also used to treat lupus and rheumatoid arthritis, the data on adverse reactions from France’s drug safety agency highlights the risk of using unproven treatments to stem a pandemic that’s killed more than 100,000 people worldwide.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • And so in regards to Spectrum, the cost per gram between the “Medium and the Large” containers is negligible? Who said “Buy in bulk (or ‘wholesale’) and save?”

Comments are closed.